Health
Biological E. Limited gets CDSCO Nod to Start Phase III Clinical Trial of its COVID-19 Vaccine Candidate – United News of India
Hyderabad, Apr 24 (UNI) Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company on Saturday announced that it has successfully completed…
Hyderabad, Apr 24 (UNI) Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company on Saturday announced that it has successfully completed the Phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India and received the approval to start the Phase III clinical trial from the Central Drugs Standard Control Organization (CDSCO) – Subject Expert Committee (SEC).BE started the Phase I/II Clinical Trial of its COVID-19 Vaccine Candidate in the second week of November…
-
General24 hours agoIslam Makhachev claims UFC welterweight belt with dominant win over Jack Della Maddalena
-
General15 hours agoAmbulance response times sluggish despite Tasmanian ramping ‘ban’ promise
-
General21 hours agoEnergy chiefs say net zero ‘irreversible’ even though bills unlikely to fall ‘for a decade’
-
Business15 hours ago3 reasons why the Vanguard MSCI Index International Shares ETF (VGS) is a top buy